中国科技论文统计源期刊 中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库(JST)
第七届湖北十大名刊提名奖  

Archive

  • Select all
    |
    特约稿
  • 特约稿
    CHANG Shuying;CHEN Shiming;CAO Qilong;LIU Ping;WANG Fugui;WANG Zhongxiao
    2002, 21(05): 263-265.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the effect of huperzine A (Hup A) to promote verbal recall in middleaged and elderly patients with dysmnesia of varying severities. Methods:50 middleaged and elderly patients with dysmnesia were given each placebo or Hup A 100μg, po, bid. for 2 weeks, according to the randomized double blind crossing medication method. Multiple selective verbal reminding tests were conducted before and after the medication. As auxiliaries, topographic mapping of the brain and determination of blood cholinesterase activity were also performed. Results:In patients with mild and moderate dysmnesia, values of Σ recall(ΣR) were increased by 0.91±3.60 and 0.86±1.79, respectively, in those given placebo, and 6.05±2.87 and 6.43±2.24, respectively, in those given Hup A. Longterm retrievel(LTR), Longterm storage(LTS), Consistent LTR(CLTR) and Unreminded recall(UrR) were also increased similarly. While the values of shortterm recall(STR) were increased by 0.90±3.32 and 0.71±2.95, respectively, in those given placebo; they were; however; decreased by 1.90±3.78 and 2.36±2.62, respectively, in those given Hup A. Similar changes were also noticed in the values of random LTR(RLTR), presentation(Pr), reminded recall(RR) and pass number(PN). There were 24 cases given placebo and only 10 cases given Hup A who could not pass the complete verbal recall tests for 11 times. Improved or normalized topographic mapping of the brain was found in 13 patients given Hup A. All these differences are statistically significant or highly significant. In contrast, Hup A was found to have no evident effect on most patients with severe dysmnesia. No severe adverse reactions and inhibition of blood cholinesterse activity were encountered during the treatment with Hup A. Conclusion:Hup A has a fair effect to improve the ability of verbal recall, retention and repetition in patients with mild and moderate dysmnesia.
  • 药物研究
  • 药物研究
    ZHU Zhirong;WANG Jinlong;TANG Chunlin
    2002, 21(05): 266-267.
    Download PDF ( )   Knowledge map   Save
    Objective:To study the bacteriostatic effect of ropivacaine. Methods:A series of solutions including 1%. 0.5%, 0.25% and 0.125% ropivacaine and lidocaine as well as normal saline were mixed with standard bacterial inocula of resuscitated Staphyococcus aureus(2 strains), Escherichia coli(2 strains), Pseudomonas aeruginosa, Enterococcus faecalis and Ureaplasma urealyticum, and were then plated to 40 well microplates. According to the broth microdilution method, absorbance was determined by an enzymometer and the rate of bacteriostasis was therby calculated. The rates of bacteriostasis of robivacaine and lidocaine in different concentrations for 7 strains of bacteria were compared, and the data were subjected to statistical analyses. Results:Lidocaine in concentrations higher than 0.5% was found to have a moderate inhibitory effect on staphyococcus aureus (ATCC 25923) and a weak suppressive effect on the other 6 strains of bacteria. Robivacaine in concentrations lower than 0.25% had no effect on Ureaplasma urealytioum, but showed aweak inhibiting effect on the other 6 strains of bacteria. The higher the concentration of robivacaine the stronger its bacteriostatic effect. The bacteriostatic effect of lidocaine was stronger than that of robivacaine(P<0.05); 1% robivacaine had a bacteriostatic effect 0.3~2.8 times stronger than that of 0.125% robivacaine while 1% lidocaine had a bacteriostatic effect 1.1~4.1 times stronger than that of 0.125% lidocaine. Conclusion:Robivacaine in the lowest concentration clinically effective for local anesthesia has a weak bacteriostatic effect.
  • 老年病用药专栏
  • 老年病用药专栏
    CHEN Yunping;MEI Yuanwu;CHENG Shiqing
    2002, 21(05): 275-276.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the therapeutic effect of huperzine A in the treatment of patients with multiinfarct dementia (MID). Methods:20 patients with MID were given each po 150 mg of huperzine A b.i,d. in a course of 6 consecutive weeks. Results:The mean MMSE score was significantly increased after the treatment (15.92±5.9) as compared with that before the treatment(10.98±4.9)(P<0.05). The total effective rate was 70.0%, while the therapeutic effects in 25.0% of the patients were scored as excellent. Conclusion:Huperzine A has a fair therapeutic effect on the cognitive function in patients with MID.
  • 老年病用药专栏
    ZHANG Jin;CHEN Jinhe
    2002, 21(05): 277-279.
    Download PDF ( )   Knowledge map   Save
    Objective:To observe the therapeutic effect and safety rate of DF521(Defibrin) in combination with fructose diphosphate in the treatment of acute cerebral infarction. Methods:80 patients with acute cerebral infarction were randomly divided into two groups with 40 cases each in group A (the treatment group) and group B (the control group). For each patient of group A, an initial dose of 10 BU DF521 was given by intravenous drip, followed by 5 BU every other day by the same route, until a total dose of 20 BU was reached. Concomitantly, 50 mL of fructose diphosphate were administered also by intravenous drip q.d. for 10 days. For group B, patients were given each 500 ml of dextran40 and 20 ml of injection danshen (Salviae Miltiorrhiza Bunge) by intravenous drip q.d. for 14 days. Results:The overall effective rate of the treatment group was 92.5% and excellent effective rate, 70.0%, while the overall effective rate of the control group was 70.0% and excellent effective rate, 37.5%. Conclusion:The therapeutic effect of DF521 in combination with fructose1, 6diphosphate was dramatic in the treatment of acute cerebral infarction. No evident side effects including hemorrhage during the treatment were encountered.
  • 药物与临床
  • 药物与临床
    XU Renshi;XIE Zunchun;WAN Hui
    2002, 21(05): 280-281.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the clinical therapeutic effects of piracetam(Pira), nerve growth peptide(NGP) and dinatril cytridini triphosphatis(CTP) in the treatment of acute cerebral infarction, so as to provide further theoretical basis for the clinical application of these remedies. Methods:Patients with acute cerebral infaction were divided into the treatment group and control group, with 50 cases in each. Patients in the treatment group were treated alone with Pira (8.0 g•d1), NGP(40 mg•d1) or CTP(80 mg•d1) separately in a course of 15 days. The treatment began within a week after the onset of the disease. Scoring of nervous function disorders and assessment of the clinical therapeutic effectiveness were carried out at the beginning and termination of the medication. Patients of the control group were those who had not been given medicines capable of activating nerve cells of the brain. Assessment of the clinical effectiveness in patients of the control group was made on the 7 th and 15 th day of the treatment. Results:The sores of nervous function disorders in patients of the treatment group were significaully decreased after the treatment as compared with those before the treatment (P<0.05). The effective rate and the total improvement rate in patients treated with Pira, NGP or CTP were markedly higher than those in patients of the control group (P<0.05). Conclusion:Pira, NGP or CTP used alone may show a fair clinical therapeutic effect in the treatment of acute cerebral infarction.
  • 药物与临床
    SONG Xuan;LIN Nan;GUO Yu xian
    2002, 21(05): 282-283.
    Download PDF ( )   Knowledge map   Save
    Objective:To study the effect of ticlopidine on blood glucose, lipid and blood rheology in patients with type Ⅱdiabetes mellitus. Methods:40 patients in the treatment group were given each 80 mg of gliclazide b.i.d. and 250 mg of ticlopidine q.d., while only 80 mg of gliclazide b.i.d were administerd to each of 20 cases in the control group. The course lasted 2 weeks in both groups. Results:The clinical cure rate were 87.5% and 65.0% in the treatment group and control group respectively. The situation of blood lipid profiles and blood rheology was much better improved in the treatment group than in the control group. The differences between these parameters of the two groups are highly significant (P<0.01). Conclusion:Ticlopidine can be used as an auxiliary medicine in the treatment of patients with type Ⅱ diabetes mellitus.
  • 药物与临床
    ZHANG Jiewen;SUO Aiqin;XIANG Li;HAN Xiong
    2002, 21(05): 283-285.
    Download PDF ( )   Knowledge map   Save
    Objective:To evaluate the therapeutic effect and safety rate of domestic buflomedil and trental in the treatment of acute cerebral infarction(ACI). Methods:102 patients with acute cerebral infarction were randomly divided into 2 groups. For the 62 patients of the treatment group, a solution of 200 mg of buflomedil in 0.9% sodium chloride was used. The solution was administered by intravenous drip with an initial dose of 100 mg of buflomedil/case on the first day, 150 mg/case on the second day and 200 mg/case qd. beginning from the third day. Likewise, a solution of 300 mg of trental in 0.9% sodium chloride was prepared for the 40 patients of the control group. 100 mg of trental were given by intravenous drip to each patient of this group on the first day, 200 mg on the second day, followed by 300 mg q.d. beginning from the third day. The course of treatment in both groups lasted 14 days. Results:The total effective rates were 90.32% and 92.22% in the treatment group and control group, respectively, at the termination of the treatment. The difference was not significant statistically. The incidences of adverse reactions in the two groups were 11.3% and 10%, respectively. These reactions, however, were mild and tolerable. Conclusion:Buflomedil is an effective and safe remedy for the treatment of acute cerebral infarction.
  • 药物与临床
    REN Jiangang;WEI Shuting;LI Huijun
    2002, 21(05): 286-287.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the clinical therapeutic effect of cerebrospinal fluid (CSF) displacement by lumbar puncture in the treatment of primary hemorrhage into partial ventricles of the brain. Methods:Patients in both the treatment group and control group were given routine remedies after admission to our hospital. Within 24 h after admission, patients of the treatment group were subjected to the first displacement of CSF by lumbar puncture. Briefly the procedure was as follows. Approximately 6 ml of CSF were let to drop out from the puncture needle and an equal amount of 0.9% sodium chloride solution was injected into the subarachnoid space. The procedore was repeated for several times until 30~50 mL of bloody CSF were displaced. CSF displacement was carried out daily for 3~5 consecutive days. Results:The total effective rate was 93.3% in patients of the treatment group and 78.6% in those of the control group. The difference was statistically highly significant (P<0.01). Conclusion:CSF displacement simply by lumbar puncture was found to have a good effect in the treatment of primary hemorrhage into partial ventricles of the brain. The procedure is safe and easy to operate.
  • 药物与临床
    YUAN Guanglei;CHEN Shiqing
    2002, 21(05): 287-288.
    Download PDF ( )   Knowledge map   Save
    Objective:To assess the therapeutic effect of longxinsu in the treatment of patients with cerebral thrombosis. Methods:50 inpatients with acute atherosclerotic cerebral thrombosis were randomly divided into the control group (20 cases) and treatment group (30 cases). To each patient of the control group, 250 mL of 20% mannifol were given by intravenous drip (for dehyration) q.d., followed by 20 mL of compound danshen (red sage root) in 250 mL of 0.9% sodium chloride solution administered by intravenous drip q.d., the course lasting 14 consecutive days. On the basis of the same treatment ordered for the patients of the control group, 1~2 pills of longxinsu were given po after meals t.i.d. to each patient of the treatment group, the course of treatment lasting 21 days. Scoring of nervous functions and inspection of hemorrheolgical indices were carried out before and after the treatment. Results:Longxinsu was capable of causing a dramatic decrease in whole blood viscosity, plasma viscosity and fibrinogen. It could also strongly promote the recovery of damaged nervous function, thereby improving the life quality of the patients. Conclusion:Longxinsu has a good therapeutic effect in the treatment of patients with cerebral thrombosis, It is safe and reliable, and devoid of toxic actions and side effects. We suggest to spread its clinical application.
  • 药物与临床
    WU Kuangming;WU Chongyang
    2002, 21(05): 289-290.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the therapeutic effect and safty rate of pantoprazole in the treatment of peptic ulcer complicated by bleeding.Methods:69 patients with confirmed diagnosis of peptic ulcer complicated by bleeding were randomly divided into the treatment group (36 cases) and control group (33 cases). To each patient of the treatment group, 40 mg of pantoprazole in 100 mL of 0.9% sodium chloride solution were given by intravenous drip q.d. Except that omerazole was used instead of pantoprazole, the treatment for patients in the control group was just the same as that in the treatment group. The course of treatment in both group lasted 3~4 days.Results:The effective rate in patients of the treatment group was 97.22%, and that of the control group, 96.96%. The difference was insignificent (P>0.05). Only mild adverse reactions were encountered in the treatment with pantoprazole. Conclusion:Pantoprazole has a definite therapeutic effect in the treatment of peplic ulcer complicated by bleeding, with little adverse reactions in short term application.
  • 药物与临床
    QU Jieming;JIANG Hongni;WANG Baoqing;HE Lixian
    2002, 21(05): 290-291.
    Download PDF ( )   Knowledge map   Save
    Objective:To evaluate the clinical therapeutic effect and safety rate of entericcoated capsules of erythromycin in the treatment of respiratory tract infections. Methods:80 patients with mild or moderate respiratory tract infection were treated with erythromycin in entericcoated capsule at a dosage of 500 mg b.i.d PO for 5~7 days. Clinical symptoms and signs before and after the treatment as well as adverse reactions to the remedy were kept under observation.Results:Of the 80 patients, 45 were cured, 26 got dramatic effects, 7 showed improvement, while 2 failed to respond to the medication. The cure rate and total effective rate were 56.3%(45/80) and 88.8%, respectively. Of the 16 bacteria strains isolated, 11 were found to be sensitive, 4 moderately sensitive, and 1 resistant to erythromyein. The eradication rate of bacteria was 93.7%. 4 patients experienced mild nausea and epigastric discomfort, 2 others had increased bowel movements. These symptoms, however, disappeared subsequently without any treatment. 2 other patients complained of nausea and vomiting, while one of them suffered form severe diarrhea(7 times•d1) and the medication was therefore suspended. The total incidence of adverse reactions was 10.8%(9/83). No abnormalities were found by liver and renal function tests in 48 patients before and after the treatment. Blood and urine routine tests in 53 patients before and after the treatment showed no abnormalities as well.Conclusion:Erythromycin in entericcoated capsules is effective and safe in the treatment of respiratory tract infections, with a high eradication rate of bacteria.
  • 药物与临床
    WANG Hanxiang;ZOU Xinrong;HE Chun;SU Guoyang
    2002, 21(05): 292-293.
    Download PDF ( )   Knowledge map   Save
    Objective:To survey the therapeutic effectiveness and adverse reactions of Taizhian capsules in the treatment of hyperlipemia (a morbid state categorized as deficient yin or deficient yin plus excessive yang of the live and kidney, according to the principle of the traditional Chinese medicine known as the overall analysis of the disease as well as the patient). Methods:300 patients with hyperlipemia were given each 3 capsules of Taizhian t.i.d. in a course of 8 consecutive weeks. Results:Taizhian capsules were found to result in an obvious improvement of the patient’s clinical syndrome as assessed by the traditional Chinese medicine. The remedy also brought about a dramatic decrease in serum triglycerides (TG), total cholesterol (TC), lowdensily lipoprotein cholesterol (LDLCh) as well as an increase in serum high density lipoprotein cholesterol (HDLCh). Conclusion:Taizhian capsules have a good therapeutic effect on hyperlipemia, with only mild adverse reactions.
  • 药品质量控制
  • 药品质量控制
    DING Shuiping;DING Shuisheng
    2002, 21(05): 303-304.
    Download PDF ( )   Knowledge map   Save
    Objective:To determine the content of ferulic acid in Tiantianfengcai granules. Methods:HPLC was used; the analytical column being Hypersil ODSZ (5 μm, 4.6 mm×250 mm). mobile phase, methanolwaterglacial acetic acid (27∶73∶1); detection wavelength, 314 nm. Results:The linear range of ferulic acid lay between 2~10 μg•ml1, r=0.999 8. The average recovery rate was 97.17% with an RSD of 2.61%. Conclusion:The method is easy to operate, with accurate and reliable results. It is therefore suitable for the quality control analysis of Tiantianfengcai granules.
  • 药物制剂
  • 药物制剂
    LIU Zuxiong;LI Xiaodong;WANG Ping;TANG Ren
    2002, 21(05): 307-308.
    Download PDF ( )   Knowledge map   Save
    Objective:To study the preparation and quality standard of pefloxacin mesylate cream. Method:The content of pefloxacin in the cream was determined with UVspectrophotometry, while its stability and irritating property were examined. Results:The average rate of recovery of the preparadfon was 99.7%, with an RSD of 0.16%. The preparation was stable its quality controllable. Conclusion: The technology of the preparation of the cream is simple and it is convenient to use the drug. We therefore suggest to spread its clinical application.
  • 药物不良反应
  • 药物不良反应
    GONG Renjie;HAN Ming;YAO Bing;LU Zhongzhen
    2002, 21(05): 317-317.
    Download PDF ( )   Knowledge map   Save
    Objective:To observe the toxic action and side effect of cyclosporine A on 23 patients after kidney transplantation. Methods:The clinical data of 23 patients treated with Cyclosporine A (6~7 mg•kg1•d1)) for 1~2 weeks after kidney transplantation were analyzed retrospectively. Results:Damage to the kidney, lesion of the liver and hypertension were found in 45%, 30% and 86%, respectively, of the 23 cases after the treatment. Conclusion:Cyclosporine A has distinct toxic actions and side effects on the kidney,liver and blood pressure.